Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Visual Function in Retinitis Pigmentosa
NCT03078309Phase 1Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Sep 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind trial of cannabis in retinitis pigmentosa (RP) (2 arms), sponsored by Hadassah Medical Organization. Primary endpoint: Electroretinogram at 3 hours. Status: unknown.
02
Drugs
cannabis
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT03078309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03078309.